Drug Shortage Report for PIPERACILLIN AND TAZOBACTAM FOR INJECTION
Report ID | 4586 |
Drug Identification Number | 02299631 |
Brand name | PIPERACILLIN SODIUM/TAZOBACTAM SODIUM POWDER FOR INJECTION |
Common or Proper name | TAZOCIN |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | PIPERACILLIN TAZOBACTAM |
Strength(s) | 3G 0.375G |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 10 VIALS |
ATC code | J01CR |
ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2017-03-27 |
Estimated end date | 2017-04-28 |
Actual end date | 2017-05-12 |
Shortage status | Resolved |
Updated date | 2017-05-17 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2017-05-17 | French | Compare |
v5 | 2017-05-17 | English | Compare |
v4 | 2017-04-18 | French | Compare |
v3 | 2017-04-18 | English | Compare |
v2 | 2017-03-28 | French | Compare |
v1 | 2017-03-28 | English | Compare |
Showing 1 to 6 of 6